• aneurysmal subarachnoid hemorrhage market to reach new heights in growth by 2034, delveinsight predicts | acasti pharma inc., bit ... Barchart.com Thu, 03 Apr 2025 13:04:00 GMT
• acasti pharma stock hits 52-week low at $2.12 amid challenges Investing.com Australia Sat, 15 Mar 2025 05:02:05 GMT
• acasti pharma stock hits 52-week low at $2.12 amid challenges Investing.com UK Fri, 14 Mar 2025 07:00:00 GMT
• can grace therapeutics' novel asah treatment impress investors at major healthcare conference? Stock Titan Tue, 25 Feb 2025 08:00:00 GMT
• ataxia telangiectasia market on track for major expansion by 2032, according to delveinsight | acasti pharma inc., intrabio inc The Globe and Mail Tue, 04 Feb 2025 00:28:32 GMT
• acasti pharma (tsxv:acst) ps ratio : (as of jan. 07, 2025) GuruFocus.com Tue, 07 Jan 2025 21:07:25 GMT
• acasti and cordenpharma look to continuous production for omega-3 drug OutSourcing-Pharma.com Mon, 09 Dec 2024 07:56:02 GMT
• acasti pharma stock soars to 52-week high of $3.61 by investing.com Investing.com Canada Thu, 05 Dec 2024 10:26:32 GMT
• acasti pharma (cve:acst) stock price up 1.8% – what’s next? Defense World Thu, 28 Nov 2024 07:11:40 GMT
• acasti pharma to report third quarter 2023 financial results on tuesday, february 14, 2023 Quantisnow Wed, 27 Nov 2024 14:02:28 GMT
• financial contrast: annexon (nasdaq:annx) & acasti pharma (nasdaq:acst) Defense World Sun, 17 Nov 2024 06:31:39 GMT
• acasti pharma inc. announces poster detailing its gtx-104 strive-on trial Marketscreener.com Wed, 30 Oct 2024 17:09:56 GMT
• acasti pharma inc. announces resignation of jean-marie canan from board of directors and member of audit committee and governance ... Marketscreener.com Tue, 29 Oct 2024 08:09:44 GMT
• otc markets hosts virtual investor presentation with prashant kohli, ceo of grace therapeutics (acasti pharma), with john vandermo... Yahoo Finance Tue, 29 Oct 2024 07:00:00 GMT
• acasti pharma insider bought shares worth $1,249,934, according to a recent sec filing Marketscreener.com Tue, 29 Oct 2024 06:58:01 GMT
• grace therapeutics announces name change and new ticker Investing.com India Tue, 29 Oct 2024 00:31:38 GMT
• grace therapeutics announces name change and new ticker Investing.com Mon, 28 Oct 2024 07:00:00 GMT
• reviewing immunic (nasdaq:imux) & acasti pharma (nasdaq:acst) Defense World Sat, 26 Oct 2024 07:00:00 GMT
• acasti pharma announces corporate name change to grace therapeutics MSN Sat, 26 Oct 2024 02:09:10 GMT
• acasti pharma transitions to grace therapeutics, trading as grce Investing.com India Sat, 26 Oct 2024 01:09:09 GMT
• acst - acasti pharma, inc. latest stock news & market updates StockTitan Fri, 25 Oct 2024 13:56:05 GMT
• Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. GlobeNewswire Fri, 25 Oct 2024 07:00:00 GMT
• acasti pharma transitions to grace therapeutics, trading as grce by investing.com Investing.com UK Fri, 25 Oct 2024 07:00:00 GMT
• acasti pharma announces corporate name change to grace therapeutics TipRanks Fri, 25 Oct 2024 07:00:00 GMT
• acasti pharma stock soars to 52-week high of $3.6 amid bullish run Investing.com India Thu, 24 Oct 2024 07:00:00 GMT
• acasti pharma stock soars to 52-week high of $3.6 amid bullish run Investing.com Wed, 23 Oct 2024 07:00:00 GMT
• acasti pharma (fra:l8s) debt-to-ebitda : 0.00 (as of jun. 2024) GuruFocus.com Thu, 17 Oct 2024 09:41:41 GMT
• acasti pharma (nasdaq:acst) stock crosses above 200 day moving average – here’s what happened Defense World Wed, 09 Oct 2024 08:07:01 GMT
• acasti pharma inc. announces poster detailing its gtx-104 strive-on trial Marketscreener.com Wed, 09 Oct 2024 03:39:10 GMT
• acasti pharma announces key corporate changes and new incentive plan by investing.com Investing.com Canada Tue, 01 Oct 2024 05:12:09 GMT
• acasti pharma announces key corporate changes and new incentive plan Investing.com Mon, 30 Sep 2024 07:00:00 GMT
• investment analysts’ price target changes for september 26th (acst, afl, ally, avap, bk, blkb, cci, chrw, cnxc, crox) Defense World Thu, 26 Sep 2024 17:21:15 GMT
• acasti pharma price target raised to $8 from $6 at craig-hallum TipRanks Thu, 26 Sep 2024 12:50:59 GMT
• acasti pharma (acst) stock surges following major clinical trial milestone Stocks Telegraph Thu, 26 Sep 2024 11:37:00 GMT
• acasti pharma shares maintain buy rating from h.c. wainwright Investing.com Thu, 26 Sep 2024 07:00:00 GMT
• acasti pharma shares gain analyst confidence, price target raised based on gtx-104 potential Investing.com India Thu, 26 Sep 2024 07:00:00 GMT
• acasti announces completion of patient enrollment in pivotal phase 3 strive-on safety trial of gtx-104 GlobeNewswire Wed, 25 Sep 2024 07:00:00 GMT
• acasti pharma inc. announces completion of patient enrollment in pivotal phase 3 strive-on safety trial of gtx-104 Marketscreener.com Wed, 25 Sep 2024 07:00:00 GMT
• acasti to participate in the h.c. wainwright 26th annual global investment conference StockTitan Thu, 05 Sep 2024 07:00:00 GMT
• will acasti pharma (nasdaq:acst) spend its cash wisely? Simply Wall St Tue, 03 Sep 2024 06:30:55 GMT
• will acasti pharma (nasdaq:acst) spend its cash wisely? Simply Wall St Mon, 02 Sep 2024 07:00:00 GMT
• acasti pharma (fra:a1p0) eps (diluted) : €-1.32 (ttm as of jun. 2024) GuruFocus.com Tue, 20 Aug 2024 09:03:10 GMT
• acasti pharma (tsxv:acst) 3-year fcf growth rate : 34.20% (as of jun. 2024) GuruFocus.com Sun, 18 Aug 2024 01:56:03 GMT
• acasti pharma (tsxv:acst) eps (diluted) : c$0.00 (ttm as of jun. 2024) GuruFocus.com Sun, 18 Aug 2024 01:22:58 GMT
• acasti pharma (tsxv:acst) enterprise value : c$-16.76 mil (as of aug. 19, 2024) GuruFocus.com Sun, 18 Aug 2024 01:21:28 GMT
• acasti pharma (tsxv:acst) 50-day sma : c$n/a (as of aug. 17, 2024) GuruFocus.com Sun, 18 Aug 2024 01:20:46 GMT
• acasti pharma (tsxv:acst) financial strength : 6 (as of jun. 2024) GuruFocus.com Sun, 18 Aug 2024 01:18:06 GMT
• acasti pharma (tsxv:acst) 14-day rsi : n/a (as of aug. 17, 2024) GuruFocus.com Sun, 18 Aug 2024 01:16:26 GMT
• acasti pharma appoints prashant kohli as ceo with incentives TipRanks Fri, 16 Aug 2024 20:44:17 GMT
• acasti pharma (fra:a1p0) cash flow from investing : €0.10 mil (ttm as of jun. 2024) GuruFocus.com Fri, 16 Aug 2024 09:33:24 GMT
• acasti pharma (fra:a1p0) earnings per share (diluted) : €-1.32 (ttm as of jun. 2024) GuruFocus.com Fri, 16 Aug 2024 09:25:28 GMT
• acasti pharma (stu:a1p0) 3-year fcf growth rate : 34.20% (as of jun. 2024) GuruFocus.com Thu, 15 Aug 2024 22:24:11 GMT
• acasti pharma (fra:a1p0) ev-to-revenue : (as of aug. 15, 2024) GuruFocus.com Thu, 15 Aug 2024 22:18:56 GMT
• acasti pharma inc. (nasdaq:acst) short interest down 49.2% in july Defense World Tue, 13 Aug 2024 15:46:03 GMT
• acasti announces first fiscal quarter 2025 financial results, provides business update GlobeNewswire Fri, 09 Aug 2024 07:00:00 GMT
• acasti pharma inc expected to post a loss of 34 cents a share - earnings preview XM Wed, 07 Aug 2024 15:39:28 GMT
• short interest in acasti pharma inc. (nasdaq:acst) increases by 281.3% Defense World Fri, 26 Jul 2024 06:19:57 GMT
• acasti pharma (nasdaq:acst) stock passes above two hundred day moving average of $2.99 Defense World Fri, 19 Jul 2024 11:04:53 GMT
• severe hypertriglyceridemia pipeline insights (2024) | clinical trials, latest approvals, treatment options, key companies | 89bio... Barchart Mon, 15 Jul 2024 15:08:16 GMT
• acasti pharma inc. (nasdaq:acst) short interest down 72.9% in june Defense World Fri, 12 Jul 2024 07:00:00 GMT
• acasti pharma (nasdaq:acst) shares cross above two hundred day moving average of $2.98 American Banking and Market News Thu, 11 Jul 2024 07:47:36 GMT
• Is Acasti Pharma (ACST) Outperforming Other Medical Stocks This Year? Yahoo Finance Wed, 10 Jul 2024 07:00:00 GMT
• new insider adar1 capital management, llc claimed ownership of 959,571 shares (sec form 3) Quantisnow Wed, 10 Jul 2024 00:46:56 GMT
• acasti pharma gaap eps of -$0.09 misses by $0.01 (nasdaq:acst) Seeking Alpha Mon, 08 Jul 2024 14:31:50 GMT
• fy2025 eps estimates for acasti pharma inc. increased by analyst (nasdaq:acst) Defense World Wed, 03 Jul 2024 11:04:53 GMT
• brokers issue forecasts for acasti pharma inc.’s q1 2025 earnings (nasdaq:acst) Defense World Tue, 02 Jul 2024 11:58:37 GMT
• brokers issue forecasts for acasti pharma inc.'s q1 2025 earnings (nasdaq:acst) Defense World Tue, 02 Jul 2024 11:58:37 GMT
• is acasti pharma (nasdaq:acst) in a good position to invest in growth? Yahoo Finance Mon, 01 Jul 2024 07:00:00 GMT
• acasti pharma inc. (nasdaq:acst) short interest update Defense World Sat, 29 Jun 2024 05:51:28 GMT
• acasti announces achievement of 50% enrollment in pivotal phase 3 strive-on safety trial StockTitan Thu, 27 Jun 2024 07:00:00 GMT
• insiders at acasti pharma see good returns after buying stock worth us$2.50m Simply Wall St Thu, 27 Jun 2024 07:00:00 GMT
• neptune, acasti and neurobiopharm announce litigation regarding its former chief executive officer Yahoo Eurosport UK Tue, 25 Jun 2024 22:57:24 GMT
• acasti pharma (nasdaq:acst) posts quarterly earnings results, beats expectations by $0.30 eps Defense World Mon, 24 Jun 2024 12:34:40 GMT
• acasti announces year-end 2024 financial results, provides business update Yahoo Finance Fri, 21 Jun 2024 07:00:00 GMT
• acst stock earnings: acasti pharma beats eps for q4 2024 InvestorPlace Fri, 21 Jun 2024 07:00:00 GMT
• acasti pharma (nasdaq:acst) stock price passes above two hundred day moving average of $2.89 Defense World Thu, 20 Jun 2024 10:37:24 GMT
• acasti pharma inc expected to post a loss of 47 cents a share - earnings preview XM Wed, 19 Jun 2024 07:00:00 GMT
• wall street favorites: 3 penny stocks with strong buy ratings for june 2024 InvestorPlace Tue, 18 Jun 2024 07:00:00 GMT
• acasti pharma inc. (nasdaq:acst) sees large increase in short interest Defense World Thu, 13 Jun 2024 06:34:35 GMT
• acasti announces preliminary topline results met all outcome measures in the pharmacokinetic bridging study for ... br.ADVFN.com Fri, 07 Jun 2024 09:31:57 GMT
• acasti pharma (nasdaq:acst) stock passes above two hundred day moving average of $2.81 Defense World Thu, 06 Jun 2024 10:23:51 GMT
• acasti announces fiscal 2013 results and provides update on status of clinical trials br.ADVFN.com Wed, 05 Jun 2024 22:01:17 GMT
• acasti pharma announces results for third quarter of fiscal 2021 br.ADVFN.com Wed, 05 Jun 2024 21:16:31 GMT
• acasti pharma (nasdaq:acst) stock price crosses below 200-day moving average of $2.79 Defense World Tue, 28 May 2024 07:17:43 GMT
• acasti pharma to attend bio international convention 2024 GlobeNewswire Tue, 28 May 2024 07:00:00 GMT
• the next novavax? 3 biopharma stocks to buy before they boom InvestorPlace Fri, 24 May 2024 08:04:13 GMT
• The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom Yahoo Finance Thu, 23 May 2024 07:00:00 GMT
• we're hopeful that acasti pharma (cve:acst) will use its cash wisely Yahoo New Zealand News Thu, 23 May 2024 05:03:00 GMT
• the next novavax? 3 biopharma stocks to buy before they boom InvestorPlace Wed, 22 May 2024 07:00:00 GMT
• insider stock buying reaches us$2.50m on acasti pharma Yahoo Finance Tue, 21 May 2024 07:00:00 GMT
• market sentiment around loss-making acasti pharma inc. (cve:acst) Yahoo Sport Australia Sun, 19 May 2024 23:18:20 GMT
• acasti pharma (nasdaq:acst) stock crosses above two hundred day moving average of $2.77 Defense World Sat, 18 May 2024 08:49:11 GMT
• has acasti pharma (acst) outpaced other medical stocks this year? Yahoo Movies UK Wed, 15 May 2024 12:10:58 GMT
• financial comparison: adc therapeutics (nyse:adct) vs. acasti pharma (nasdaq:acst) Defense World Sun, 12 May 2024 05:36:10 GMT
• acasti pharma (acst) stock forecast and price target 2025 MarketBeat Sat, 11 May 2024 16:21:47 GMT
• acasti pharma inc. (nasdaq:acst) sees significant decrease in short interest Defense World Sat, 11 May 2024 07:55:07 GMT
• proactive news headlines including power reit, delta 9 cannabis, bragg gaming and acasti pharma The Globe and Mail Tue, 07 May 2024 01:40:36 GMT
• global hypertriglyceridemia treatment market report analysis bus News Channel Nebraska Sat, 04 May 2024 12:43:18 GMT
• acst (acasti pharma) 3-year book growth rate : -20.00% (as of jun. 2024) GuruFocus.com Wed, 01 May 2024 06:49:52 GMT
• acasti pharma (nasdaq:acst) stock price passes above 200 day moving average of $2.74 Defense World Fri, 26 Apr 2024 07:43:08 GMT
• short interest in acasti pharma inc. (nasdaq:acst) grows by 171.4% Defense World Fri, 26 Apr 2024 05:32:07 GMT
• the 8 best stocks under $2 to buy for september 2024 ! The Stock Dork Mon, 22 Apr 2024 07:00:00 GMT
• we're keeping an eye on acasti pharma's (nasdaq:acst) cash burn rate Simply Wall St Sat, 20 Apr 2024 07:00:00 GMT
• acasti pharma (nasdaq:acst) stock passes above 200-day moving average of $2.73 Defense World Thu, 18 Apr 2024 08:03:35 GMT
• acasti pharma inc. (nasdaq:acst) short interest down 78.8% in march Defense World Thu, 11 Apr 2024 08:37:14 GMT
• acasti pharma (nasdaq:acst) stock passes above two hundred day moving average of $2.65 Defense World Thu, 04 Apr 2024 07:45:47 GMT
• short interest in acasti pharma inc. (nasdaq:acst) decreases by 71.6% Defense World Thu, 28 Mar 2024 07:11:22 GMT
• acasti and neptune provide update on patent litigations with enzymotec br.ADVFN.com Sat, 23 Mar 2024 18:41:32 GMT
• acasti pharma (nasdaq:acst) stock passes above two hundred day moving average of $2.56 Defense World Fri, 22 Mar 2024 08:25:06 GMT
• acasti pharma announces issuance of common shares in payment of outstanding interest under debentures Yahoo News UK Wed, 13 Mar 2024 14:06:50 GMT
• acasti pharma inc. (nasdaq:acst) sees large increase in short interest Defense World Wed, 13 Mar 2024 07:18:38 GMT
• acasti pharma inc. (nasdaq:acst) short interest up 105.3% in february American Banking News Wed, 13 Mar 2024 07:14:14 GMT
• acasti pharma (nasdaq:acst) shares pass above 200-day moving average of $2.46 Defense World Fri, 08 Mar 2024 08:52:12 GMT
• acasti pharma (nasdaq:acst) shares pass above 200 day moving average of $2.46 American Banking News Fri, 08 Mar 2024 08:51:53 GMT
• acasti pharma announces issuance of common shares in payment of outstanding interest under debentures Yahoo News UK Thu, 07 Mar 2024 15:48:07 GMT
• ataxia telangiectasia market to observe impressive growth during the forecast period (2023-2032), evaluates delveinsight | acasti ... The Globe and Mail Thu, 07 Mar 2024 08:00:00 GMT
• acasti pharma inc. (cve:acst) insiders increased their holdings Yahoo Movies UK Wed, 06 Mar 2024 17:29:30 GMT
• subarachnoid hemorrhage market to grow at a substantial growth rate during the forecast period (2023-2032 ... 매일세종 Fri, 01 Mar 2024 14:24:52 GMT
• brain hemorrhage market is projected to boost at a moderate growth rate during the forecast period (2023-2032 ... 매일세종 Thu, 29 Feb 2024 20:12:15 GMT
• acasti pharma inc. (nasdaq:acst) short interest update American Banking News Thu, 29 Feb 2024 06:50:14 GMT
• acasti pharma to participate in oppenheimer 33rd annual healthcare conference (pr newswire) Aktiellt Tue, 27 Feb 2024 20:36:29 GMT
• acasti pharma announces annual grants of performance stock options The Globe and Mail Sat, 24 Feb 2024 10:30:00 GMT
• Acasti Pharma (ACST) Price Target Increased by 200.00% to 6.12 Nasdaq Sat, 24 Feb 2024 08:00:00 GMT
• acasti pharma (nasdaq:acst) stock passes above 200 day moving average of $2.38 Defense World Thu, 22 Feb 2024 09:29:34 GMT
• acasti pharma (nasdaq:acst) stock price crosses above two hundred day moving average of $2.38 American Banking News Thu, 22 Feb 2024 08:00:00 GMT
• potential price increase for acasti pharma inc (acst) after recent insider activity – knox daily Knox Daily Mon, 19 Feb 2024 18:03:58 GMT
• acasti pharma appoints healthcare industry leader michael l. derby to its board of directors The Globe and Mail Sat, 17 Feb 2024 07:41:24 GMT
• short interest in acasti pharma inc. (nasdaq:acst) expands by 20.4% AmericanBankingNEWS Thu, 15 Feb 2024 08:00:00 GMT
• should you buy acasti pharma inc (acst) stock after it has risen 18.64% in a week? InvestorsObserver Wed, 14 Feb 2024 08:00:00 GMT
Acasti Pharma Inc(NASDAQ:ACST) 
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patie...
Website: http://www.acastipharma.com
Founded: 2002
Full Time Employees: 32
Sector: Healthcare
Industry: Biotechnology